Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy

NCT00256841 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Chemotherapy
PROCEDURE: Radiation Therapy

Sponsor

Clinical Oncology Research Associates